These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1381110)
1. Development of a malaria T-cell vaccine for blood stage immunity. Quakyi IA; Taylor DW; Johnson AH; Allotey JB; Berzofsky JA; Miller LH; Good MF Scand J Immunol Suppl; 1992; 11():9-16. PubMed ID: 1381110 [TBL] [Abstract][Full Text] [Related]
2. Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria. Avila SL; Goldberg AC; Arruk VG; Marin ML; Guilherme L; Kalil J; Ferreira AW Parasite Immunol; 2001 Feb; 23(2):103-8. PubMed ID: 11240901 [TBL] [Abstract][Full Text] [Related]
3. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577 [TBL] [Abstract][Full Text] [Related]
4. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens. Chatterjee S; Sharma P; Kumar S; Chauhan VS Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829 [TBL] [Abstract][Full Text] [Related]
5. Sporozoite malaria vaccine. Where do we stand? Nussenzweig V; Nussenzweig S Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271 [TBL] [Abstract][Full Text] [Related]
6. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Zevering Y; Khamboonruang C; Good MF Immunology; 1998 Jul; 94(3):445-54. PubMed ID: 9767430 [TBL] [Abstract][Full Text] [Related]
7. Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria. Caro-Aguilar I; Lapp S; Pohl J; Galinski MR; Moreno A Microbes Infect; 2005 Oct; 7(13):1324-37. PubMed ID: 16253535 [TBL] [Abstract][Full Text] [Related]
8. Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Perlmann H; Perlmann P; Berzins K; Wåhlin B; Troye-Blomberg M; Hagstedt M; Andersson I; Högh B; Petersen E; Björkman A Immunol Rev; 1989 Dec; 112():115-32. PubMed ID: 2481640 [TBL] [Abstract][Full Text] [Related]
9. Malaria vaccines: immunogen selection and epitope mapping. Perlmann P; Berzins K; Perlmann H; Troye-Blomberg M; Wahlgren M; Wåhlin B Vaccine; 1988 Apr; 6(2):183-7. PubMed ID: 2455387 [TBL] [Abstract][Full Text] [Related]
10. Differential T-cell responses of semi-immune and susceptible malaria subjects to in silico predicted and synthetic peptides of Plasmodium falciparum. Dinga JN; Kimbung Mbandi S; Cho-Ngwa F; Fon NP; Moliki J; Efeti RM; Nyasa BR; Anong DN; Jojic N; Heckerman D; Wang R; Titanji VP Acta Trop; 2014 Jul; 135():104-21. PubMed ID: 24681218 [TBL] [Abstract][Full Text] [Related]
11. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design. Amante FH; Crewther PE; Anders RF; Good MF J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494 [TBL] [Abstract][Full Text] [Related]
12. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. Quakyi IA; Currier J; Fell A; Taylor DW; Roberts T; Houghten RA; England RD; Berzofsky JA; Miller LH; Good MF J Immunol; 1994 Sep; 153(5):2082-92. PubMed ID: 8051413 [TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals. Ohta N; Iwaki K; Itoh M; Fu J; Nakashima S; Hato M; Tolle R; Bujard H; Saitoh A; Tanabe K Int Arch Allergy Immunol; 1997 Sep; 114(1):15-22. PubMed ID: 9303326 [TBL] [Abstract][Full Text] [Related]
14. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. Hoffman SL; Oster CN; Mason C; Beier JC; Sherwood JA; Ballou WR; Mugambi M; Chulay JD J Immunol; 1989 Feb; 142(4):1299-303. PubMed ID: 2464643 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134 [TBL] [Abstract][Full Text] [Related]
16. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites. Calvo-Calle JM; Oliveira GA; Nardin EH J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667 [TBL] [Abstract][Full Text] [Related]
17. The implications for malaria vaccine programs if memory T cells from non-exposed humans can respond to malaria antigens. Good MF Curr Opin Immunol; 1991 Aug; 3(4):496-502. PubMed ID: 1755974 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study. Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531 [TBL] [Abstract][Full Text] [Related]
19. Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines. Cockburn I Methods Mol Biol; 2013; 923():465-79. PubMed ID: 22990798 [TBL] [Abstract][Full Text] [Related]
20. Malaria antigens and MHC restriction. Sinigaglia F; Guttinger M; Romagnoli P; Takacs B Immunol Lett; 1990 Aug; 25(1-3):265-70. PubMed ID: 2283157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]